Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

News

 

Further Notifications

Here you find all press releases and further notifications, as well as all events of Fraunhofer ITMP.

Press Release / 13.7.2026

The Fraunhofer Institute for Translational Medicine and Pharmacology ITMP marks another milestone for the science and pharmaceutical location of Bavaria.

The Fraunhofer ITMP today celebrated the topping-out ceremony for the new site of Immunology, Infection, and Pandemic Research (IIP) in Penzberg/Munich, after completion of the shell construction works. High-level representatives such as Dr. Markus Söder (Bavaria's Minister-President), Alexander Dobrindt (Federal Minister of the Interior), Hubert Aiwanger (Bavarian Minister of Economy, Regional Development and Energy), and Markus Blume (Minister of State for Science and Art) praised the construction progress and emphasized the great potential for biomedical innovations and international competitiveness.

New Research Project / 28.5.2026

Infection research Using data against ticks: New ways to predict disease risks

MONID HABITRACK uses drones and artificial intelligence to research the spread of tick-borne diseases in the districts of Amberg-Sulzbach and Schwandorf

Press Release / 18.5.2026

Research on a new therapeutic approach for chronic urticaria

1.3-million-euro funding for the Eurostars project MastCURe: The Fraunhofer Institute for Translational Medicine and Pharmacology ITMP Immunology and Allergology IA in Berlin will conduct research over the next 3 years together with Allegria Therapeutics and Cube Biotech on a novel therapeutic approach to treating chronic urticaria. 

Research Divisions

Fraunhofer ITMP is organized in 3 cross-site research divisions.

 

Drug Discovery

 

From target to screening to lead optimization and formulation.

 

Preclinical Research

 

Translational cycles and OMICs analyses for characterization of biological mechanisms and novel targets.

 

Clinical Research

 

From „Proof-of-Concept“ to the characterization of established products: “Quality by Design” for successful translation of innovative ideas.

Innovation Platforms

Through its innovation platforms, Fraunhofer ITMP is optimally networked both internally and externally with other Fraunhofer Institutes, universities, and industry. This provides the conditions for transdisciplinary and flexible collaboration in the fields of new technologies, disease models, and therapeutic concepts.

Institute Locations

 

Headquarters of Fraunhofer ITMP

Frankfurt am Main

 

The site has strong expertise in pharmacology and clinical trials in immune-mediated diseases and pain. 

Discovery Research ScreeningPort

Hamburg

 

The site has strong expertise in high-throughput drug discovery (in silico, in vitro screening and drug repurposing) as well as a broad offering in "medical data science".

Translational Neuroinflammation and Automated Microscopy TNM

Göttingen

The site has strong expertise in high- and super-resolution microscopy techniques; as well as neuroinflammation and degenerative diseases.

Immunology and Allergology IA

Berlin


The site has strong expertise in dermatology, allergology, and immunological mast cell-mediated inflammatory diseases of the skin.

Immunology, Infection and Pandemic Research IIP

Penzberg/Munich


The site has strong expertise in developing interventions to address the outbreak of new and spread of existing infectious diseases.